** Shares of medtech firm Lensar LNSR.O fall 3.7% to $14.27

** LNSR has agreed to be acquired by Swiss eyecare firm Alcon ALCC.S for $14/shr, totaling around $356 million

** Deal represents a 5.6% discount to LNSR's last close

** U.S.-listed shares of Alcon ALC.N up 1.8% at $92.18

** Alcon may pay Lensar an additional $2.75/shr, totaling up to $430 million, if certain procedure targets are met

** Deal is expected to close in mid-to-late 2025

** LNSR up more than four-fold and U.S.-listed shares of ALC up 7.9% in the last 12 months

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))